Skip to main content
Contact Us
Subscribe
E-Edition
54°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about REGN
Recent news which mentions REGN
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
29
30
Next >
The 7 Most Undervalued Nasdaq Stocks to Buy in February 2023
February 01, 2023
Tickers
BIIB
CHTR
CTSH
INTC
Tags
NASDAQ:MRNA,NASDAQ:INTC,NASDAQ:CTSH,NASDAQ:REGN,NASDAQ:BIIB,NASDAQ:CHTR,NASDAQ:MU
Stocks to Buy
MU
From
InvestorPlace
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,300 Today
February 01, 2023
Tickers
REGN
Tags
Benzinga
Dividends
BZI/POD
From
Benzinga
February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More
January 31, 2023
Tickers
APLS
BIIB
CYTK
EBS
Tags
CYTK
FDA
SGEN
From
Benzinga
7 CRISPR Stocks With the Best Long-Term Potential
January 30, 2023
Tickers
BEAM
BIIB
CLLS
CRSP
Tags
CLLS
SGMONYSE
EDIT
From
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For January 30, 2023
January 30, 2023
Tickers
ACN
ATER
AXTA
AZEK
Tags
BMRN
CELU
UBER
From
Benzinga
Europe Approves Regeneron-Sanofi's Dupixent For Expanded Use In Eosinophilic Esophagitis
January 30, 2023
Tickers
REGN
SNY
Tags
Market News
Benzinga
SNY
From
Benzinga
What 8 Analyst Ratings Have To Say About Regeneron Pharmaceuticals
January 30, 2023
Tickers
REGN
Tags
BZI/AAR
REGN
Benzinga
From
Benzinga
Can Market Sustain Upward Momentum In Tech-Heavy Earnings Week? Apple, Amazon, AMD, Alphabet, Ford Among Key Quarterly Reports To Watch
January 29, 2023
Tickers
AAPL
AMD
AMGN
AMZN
Tags
AMGN
MSFT
TMUS
From
Benzinga
Wall Street Thinks These 2 Blazing Healthcare Stocks Could Have 21% to 30% Upside in 2023
January 23, 2023
Tickers
ELV
REGN
SNY
Tags
SNY
Market News
ELV
From
Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 20, 2023
January 20, 2023
Tickers
ACGL
AFG
AIG
AJG
Tags
Initiation
IIPR
LCII
From
Benzinga
Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years
January 19, 2023
Tickers
REGN
Tags
BZI/POD
REGN
Benzinga
From
Benzinga
Analyst Ratings for Regeneron Pharmaceuticals
January 11, 2023
Tickers
REGN
Tags
Analyst Ratings
Market News
REGN
From
Benzinga
Check Out What Whales Are Doing With REGN
January 10, 2023
Tickers
REGN
Tags
Benzinga
Options
REGN
From
Benzinga
Check Out What Whales Are Doing With REGN
January 09, 2023
Tickers
REGN
Tags
Markets
BZI/UOA
Market News
From
Benzinga
What This Drug News Could Mean for Sanofi Shareholders
January 08, 2023
Tickers
REGN
SNY
Tags
Recent Press Releases
REGN
SNY
From
Motley Fool
5 Top Pharma Stocks of 2022 to Buy for the Long Haul
January 06, 2023
Tickers
ABT
AMGN
BAC
BMY
Tags
WFC
MRNA
REGN
From
InvestorPlace
CytomX Shares Move Higher On Collaborating Pact With This Famed COVID-19 Vaccine Maker
January 06, 2023
Tickers
CTMX
MRNA
REGN
Tags
REGN
Health Care
MRNA
From
Benzinga
3 Growth Stocks That Could Rocket Higher in 2023
January 06, 2023
Tickers
ALNY
QURE
REGN
Tags
REGN
Recent Press Releases
QURE
From
Motley Fool
Jim Cramer Says He's 'Still Feeling Good' About These 5 Stocks From 'Mutilated' Nasdaq
January 05, 2023
Tickers
AEP
DLTR
PEP
PG
Tags
Analyst Color
Jim Cramer
Markets
From
Benzinga
2 Unstoppable Dividend Growth Stocks to Buy in 2023 and Beyond
December 29, 2022
Tickers
AMGN
CVS
REGN
Tags
REGN
CVS
AMGN
From
Motley Fool
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
December 27, 2022
Tickers
BGNE
BIIB
CDTX
CHRS
Tags
PHAT
News
FDA Approval
From
Benzinga
2 Market-Beating Stocks to Buy in 2023 and Hold Forever
December 24, 2022
Tickers
AMGN
AZN
HZNP
JNJ
Tags
NVO
AMGN
Market News
From
Motley Fool
Ahead of a year of big unknowns, here are two sectors investors should consider, says this money manager
December 22, 2022
Tickers
AAL
AAPL
AMC
AMZN
Tags
SPX
NQ00
MU
From
MarketWatch
2 Best Biotech Stocks to Buy Right Now
December 16, 2022
Tickers
AMGN
AZN
REGN
SNY
Tags
AMGN
Recent Press Releases
REGN
From
Motley Fool
Regeneron-Sanofi's Dupixent Wins European Approval For Prurigo Nodularis
December 15, 2022
Tickers
REGN
SNY
Tags
European Medicines Agency
REGN
News
From
Benzinga
Regeneron Reveals An Early Cut Data From Follicular Lymphoma Study At ASH Meeting
December 13, 2022
Tickers
REGN
Tags
General
Health Care
REGN
From
Benzinga
Regeneron Highlights Its First Phase 2 Data To Build Case In CD20xC3 Bispecific Space
December 12, 2022
Tickers
REGN
Tags
REGN
General
Health Care
From
Benzinga
Our 7 Top Biotech Stock Picks for 2023
December 09, 2022
Tickers
CORT
GMAB
NVO
REGN
Tags
NASDAQ:REGN,NASDAQ:UTHR,NASDAQ:VRTX,NASDAQ:CORT,NASDAQ:GMAB,NYSE:NVO,NASDAQ:TECH
REGN
GMAB
From
InvestorPlace
Will This Potential Approval Be a Winner for Sanofi's Shareholders?
December 09, 2022
Tickers
REGN
SNY
Tags
Market News
SNY
REGN
From
Motley Fool
This fund beats the S&P 500 by using just 75 of its components. Here’s how it works.
December 08, 2022
Tickers
AAPL
AMZN
BRK-B
CI
Tags
AMZN
GOOG
CI
From
MarketWatch
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
29
30
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.